Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

1.10
Delayed Data
As of Apr 24
 +0.03 / +2.80%
Today’s Change
0.80
Today|||52-Week Range
1.82
+20.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues1.8M1.1M2.2M22.9M
 
 
 
 
 
Depreciation And Amortization4.9M4.2M2.9M1.9M
 
 
 
 
 
 
Operating ExpensesGross Income-3.0M------
 
 
General Expenses103.5M95.4M103.9M101.2M
 
 
 
 
 
Research And Development91.8M78.4M89.7M84.4M
 
 
 
 
 
Total Operating Expenses108.4M99.6M106.8M103.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-106.5M-98.5M-104.6M-80.2M
 
 
 
 
 
Extraordinary Credit0.000.002.2M--
 
 
Extraordinary Charge-7.6M-9.9M0.00-20.1M
 
 
 
 
Interest Expense On Debt2.5M2.1M2.0M2.3M
 
 
 
 
 
Other Expenses153.0K105.0K59.0K2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-116.2M-110.2M-104.1M-100.4M
 
 
 
 
 
Income Taxes0.000.000.00-70.0K
 
 
Net Income-116.2M-110.2M-104.1M-100.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS340.8M489.7M513.1M534.4M
 
 
 
 
 
Shares To Calculate EPS Diluted340.8M489.7M513.1M534.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.34-$0.23-$0.20-$0.19
 
 
 
 
 
EPS Diluted-$0.34-$0.23-$0.20-$0.19
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account